DealForma
Depends
Confidence: Medium
Buy if you're a biopharma BD, corp-dev, or investment team needing curated licensing, M&A, and venture comps.
Comparison
DealForma and PitchBook both land on Depends.
Buy if you're a biopharma BD, corp-dev, or investment team needing curated licensing, M&A, and venture comps.
Buy only if you're a VC, PE, or M&A team pulling private-market deal data daily.
| Compare | DealForma | PitchBook |
|---|---|---|
| Verdict | Depends | Depends |
| Best for | Biopharma BD teams | VC and PE deal teams |
| Who it's not for | Anyone outside biopharma . zero coverage elsewhere | Startups fundraising on a budget |
| Privacy | No known public vulnerabilities found in the sources reviewed.12 | No known public vulnerabilities found in the sources reviewed. |
| Support quality | Hands-on case studies, but vendor is tiny | Full-service onboarding advertised; thin independent data |
| Public sentiment | Independent reviews are scarce; third-party guides praise its curated biopharma focus and its own site shows strong customer testimonials.³ | Users praise the data depth and feature set but repeatedly call the pricing exorbitant and flag a buggy Excel plugin.15 |
| Biggest gotcha | ~$18K individual seat; team pricing likely quote-based . confirm costs before demo³ | Opaque, negotiated pricing; expect five-figure annual contracts per seat |